NASDAQ · Stocky rates: Cautious

HCSG

$22.84 ▼ -1.34% as of 5 Aug, 20:00
55
/ 100
Neutral

What Stocky thinks

Cautious. HCSG exhibits mid-cycle growth (55 GCS) with balanced leadership alignment (67 LAS) driven by founder-CEO stewardship, but faces material structural vulnerability: dependency on healthcare staffing cycles and labor cost inflation erodes margins without pricing power. Valuation at 19.8× forward earnings leaves limited room for deceleration.

Compounder Score
55/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
67/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
50/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
49/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for HCSG:

55
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 55/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

67
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

50
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

HCSG (HCSG) — frequently asked

Is HCSG (HCSG) a good investment right now?

Stocky rates HCSG (HCSG) at 55/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. HCSG exhibits mid-cycle growth (55 GCS) with balanced leadership alignment (67 LAS) driven by founder-CEO stewardship, but faces material structural vulnerability: dependency on healthcare staffing cycles and labor cost inflation

What is HCSG's Stocky Verdict?

HCSG's current Stocky Verdict is 55/100, placing it in the "Cautious" band. This composite combines a 55/100 Compounder score, 67/100 Leadership, Moat rating, and analyst signal.

Does HCSG have a competitive moat?

Stocky hasn't finalised a Moat Score for HCSG yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is HCSG's leadership aligned with shareholders?

HCSG scores 67/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to HCSG?

HCSG's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to HCSG.

This is just the surface. See the whole picture on HCSG.

Sign up free and unlock the full analysis on HCSG — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering HCSG — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for HCSG.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how HCSG changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to HCSG?" · "Is HCSG overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
55
/ 100 · Neutral

Or jump straight to the interactive dashboard for HCSG in the app.